Drug production in Russia hits record low so far this year

The production of drugs in Russia this year may show record low figures, due to the current glut in the Russian pharmaceutical market and the reduction of morbidity rate in certain disease areas, according to recently published data of the Russian Ministry of Health, reports The Pharma Letter’s local correspondent.

According to data of the Ministry, during the January-April 2018 period, total production of drugs in Russia amounted to about 100 billion roubles ($1.6 billion) in value terms. This is 22% less than in the same period in 2017 and the lowest figure for the last three years.

The biggest decline is observed in the case of antiviral drugs, which are produced both by local drugmakers and foreign companies operating in Russia.